Chemical carrier based on a beta-limit dextrin
AssigneeGlycologic Limited
InventorsRichard Tester, Xin Qi
Life of this patent
Estimating the term…
Abstract
A formulation, especially a pharmaceutical formulation, comprises an active agent and a carrier for the active agent, wherein the carrier comprises a beta-limit dextrin. The formulation may be a bioadhesive pharmaceutical formulation in which the beta-limit dextrin acts as a mucoadhesive agent. The active agent is a pharmaceutically active agent or a flavour or fragrance which is intended for delivery into the buccal cavity. A use of beta-limit dextrin as a disintegrant, a dispersant, and a mucoadhesive agent is also described. Also described is a nutritional product such as an energy drink which includes beta-limit dextrin as an energy source.
Claims35
A bioadhesive pharmaceutical formulation comprising an active agent and a mucoadhesive carrier for the active agent, wherein the mucoadhesive carrier comprises a β-limit dextrin.
(canceled)
(canceled)
(canceled)
A nutritional product comprising β-limit dextrin in which the β-limit dextrin is a main energy source in the product.
(canceled)
(canceled)
(canceled)
(canceled)
A method for delivering an active agent to a mucosal membrane of a mammal comprising administering to said mammal a formulation comprising said active agent and a mucoadhesive carrier for the active agent, wherein the mucoadhesive carrier comprises a β-limit dextrin.
A method of providing nutrition to a subject comprising administering to the subject a nutritional product comprising a β-limit dextrin as an energy source.
Dependencies are inferred from the claim text.